Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Visco, Carlo;Tecchio, Cristina;Merli, Michele;Ruggeri, Marco;
2019-01-01

Abstract

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
2019
allogeneic transplant; cytarabine; mantle cell lymphoma; prognosis; refractory
File in questo prodotto:
File Dimensione Formato  
Visco_et_al-2018-British_Journal_of_Haematology(2).pdf

accesso aperto

Tipologia: Documento in Pre-print
Licenza: Accesso ristretto
Dimensione 135.92 kB
Formato Adobe PDF
135.92 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1014819
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 49
  • ???jsp.display-item.citation.isi??? 49
social impact